Fosaprepitant - NDC Database

37 records found
Page:1Last Page
0338-0008 Sep 05, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
0591-4385 Sep 19, 2019
Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
0781-3497 Sep 02, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc.
16714-120 Jan 16, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
16714-248 Jan 28, 2023
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
16714-929 Mar 20, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
16729-240 Oct 22, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
25021-784 Dec 15, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
31722-165 Jul 29, 2021
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
43598-859 Sep 06, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
43598-948 Jul 01, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
60505-6105 Sep 05, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
63323-972 Sep 05, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
67457-888 Sep 05, 2019
Fosaprepitant 115 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
67457-889 Sep 05, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
68001-421 Nov 20, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68001-517 Aug 23, 2021
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68001-523 Feb 02, 2022
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68180-690 Sep 25, 2020
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Lupin Pharmaceuticals, Inc.
69097-830 Sep 05, 2019
Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.
Page:1Last Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.